AI-generated summary
This narrative review synthesized mechanistic and preclinical evidence on photobiomodulation for migraine, drawing on PubMed/MEDLINE literature. The authors report that photobiomodulation may affect mitochondrial function, inflammation and neurovascular signaling, and that animal models relevant to migraine showed reduced hyperalgesia and oxidative stress. They state that migraine-specific clinical evidence remains limited and that controlled clinical trials are needed.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract states that migraine-specific evidence remains limited and that the review relies largely on mechanistic and preclinical rather than clinical studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Migraine, Low-level laser therapy, Adenosine triphosphate, Neuroinflammation, Oxidative stress, Neuroplasticity, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.